Renaissance Technologies’s Acutus Medical Inc AFIB Stock Holding History

Renaissance Technologies’s Portfolio AFIB Stock Details AFIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-347,800	Closed	-$65K	–	4095
2024 Q1	$65K	Buy	347,800 +20,800	+6%	+$4.11K	﹤0.01%	3442
2023 Q4	$66K	Buy	327,000 +11,600	+4%	+$4.54K	﹤0.01%	3399
2023 Q3	$220K	Sell	315,400 -54,500	-15%	-$35.3K	﹤0.01%	3057
2023 Q2	$328K	Sell	369,900 -24,900	-6%	-$21.1K	﹤0.01%	3089
2023 Q1	$298K	Buy	394,800 +90,300	+30%	+$118K	﹤0.01%	3125
2022 Q4	$350K	Sell	304,500 -98,200	-24%	-$81.1K	﹤0.01%	3158
2022 Q3	$354K	Buy	402,700 +141,100	+54%	+$171K	﹤0.01%	3123
2022 Q2	$293K	Sell	261,600 -97,100	-27%	-$83.3K	﹤0.01%	3471
2022 Q1	$499K	Buy	+358,700	New	+$767K	﹤0.01%	3199
2021 Q4	–	Sell	-31,586	Closed	-$279K	–	4306
2021 Q3	$279K	Buy	+31,586	New	+$416K	﹤0.01%	3107

Other funds holding AFIB

SAM

S.A. Mason Holland, Michigan $266M AUM 26.42% 1-Year Est. Return

Renaissance Technologies's AFIB Position: Q2 2024 in Review

Renaissance Technologies sold out of Acutus Medical Inc (AFIB) in Q2 2024, closing a stake of 347,800 shares — an estimated $65K sold.

Renaissance Technologies first reported a position in AFIB in Q3 2021 and held it in 10 quarters. The position peaked at $499K in Q1 2022. 1 fund tracked by Wall St. Rank holds AFIB as of Q2 2024.

Renaissance Technologies reported no remaining Acutus Medical Inc position as of Q2 2024 after selling out during the quarter.
Renaissance Technologies sold 347,800 Acutus Medical Inc shares in Q2 2024, an estimated $65K.
Renaissance Technologies first reported a position in Acutus Medical Inc in Q3 2021 and held it in 10 quarters.
Renaissance Technologies's Acutus Medical Inc position peaked at $499K in Q1 2022.
1 fund tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2024.

Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.